|
HRMY Harmony Biosciences Holdings Inc 1802665 |
| Balance Sheet |
|
Current Assets
|
$814,334,000.00 |
|
Assets
|
$1,373,084,000.00 |
|
Current Liabilities
|
$234,070,000.00 |
|
Liabilities
|
$373,841,000.00 |
|
Equity
|
$999,243,000.00 |
|
Shares Out
|
58120695.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$120,192,000.00 |
|
Investing Cash Flow
|
$-315,149,000.00 |
| Market Analysis |
Market Cap
|
$2,212,654,858.65 |
|
Price
|
$38.07 |
|
BVPS
|
17.19 |
|
PB
|
2.21 |
|
EPS
|
1.30 |
|
PE
|
14.26 |
|
PS
|
2.12 |
|
FCF
|
$119,882,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
0.57 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
0.55 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
0.92 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
1.08 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HRMY documents filed with the SEC.
HRMY Filings
Clear
